Rapport Therapeutics (RAPP)'s 30-day implied volatility (IV30) was 76.3% at the close on November 13, 2026, down from 77.4% the day before, against a 52-week range of 50.2% to 111.3%. Its 20-day historical volatility was 88.5%.
Data as of November 13, 2026.